C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/82 (2006.01) A61K 31/44 (2006.01) A61K 31/4439 (2006.01) A61K 31/444 (2006.01) A61P 29/00 (2006.01) C07D 401/06 (2006.01) C07D 401/12 (2006.01) C07D 403/06 (2006.01) C07D 405/12 (2006.01) C07D 407/12 (2006.01) C07D 409/12 (2006.01)
Patent
CA 2500231
The present invention relates to novel pyridine derivatives, pharmaceutical compositions containing these compounds and their use in the treatment of diseases, particularly pain, which diseases are caused directly or indirectly by an increase or decrease in activity of the cannabinoid receptor.
L'invention concerne de nouveaux dérivés de pyridine représentés par la formule (I), des compositions pharmaceutiques contenant ces composés et l'utilisation de ceux-ci pour le traitement de pathologies, en particulier de la douleur, qui sont causées directement ou indirectement par un accroissement ou une diminution de l'activité du récepteur cannabinoïde.
Eatherton Andrew John
Giblin Gerard Martin Paul
Green Richard Howard
Jandu Karamjit Singh
Mitchell William Leonard
Glaxo Group Limited
Gowling Lafleur Henderson Llp
LandOfFree
Pyridine derivatives as cb2 receptor modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridine derivatives as cb2 receptor modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridine derivatives as cb2 receptor modulators will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1608702